Pregnancy Prevention Program Section of the Risk Management Plan for Soriatane® (acitretin): Survey to Assess Physician and Pharmacist Understanding of the Risk of Teratogenicity Associated with Soriatane

14/11/2017
02/07/2024
EU PAS number:
EUPAS21151
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other

Data sources (types), other

This is a one-time survey study of Canadian physicians and pharmacists. Two separate survey questionnaires will be developed for physicians and pharmacists.
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

Unknown